Jan A Staessen Selected Research

Nitrendipine

4/2010	Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial.
5/2003	What can be expected from optimal blood pressure control?
10/2001	How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan A Staessen Research Topics

Disease

101	Hypertension (High Blood Pressure) 01/2022 - 01/2002
31	Heart Failure 01/2022 - 06/2003
22	Stroke (Strokes) 01/2021 - 07/2002
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2002
13	Inflammation (Inflammations) 01/2022 - 08/2009
12	Myocardial Infarction 01/2020 - 07/2002
11	Diabetes Mellitus 03/2020 - 11/2002
11	Left Ventricular Dysfunction 01/2019 - 03/2009
10	Essential Hypertension 01/2021 - 12/2002
9	Fibrosis (Cirrhosis) 01/2022 - 12/2010
9	Chronic Renal Insufficiency 01/2021 - 01/2014
9	Isolated Systolic Hypertension 01/2011 - 10/2001
8	Dementia (Dementias) 01/2021 - 10/2002
7	Coronary Disease (Coronary Heart Disease) 11/2021 - 10/2003
5	Body Weight (Weight, Body) 01/2020 - 04/2003
5	Insulin Resistance 01/2018 - 04/2003
4	Proteinuria 01/2019 - 09/2002
4	Albuminuria 01/2018 - 09/2010
4	White Coat Hypertension 01/2016 - 01/2002
4	Neoplasms (Cancer) 09/2015 - 02/2006
3	Pathologic Processes 01/2022 - 11/2021
3	Cognitive Dysfunction 01/2021 - 08/2003
3	Masked Hypertension 01/2019 - 05/2013
3	Renal Hypertension 05/2015 - 08/2002
2	COVID-19 10/2021 - 06/2021
2	Kidney Diseases (Kidney Disease) 10/2021 - 01/2017
2	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 12/2006
2	Hemorrhage 03/2020 - 01/2019
2	Diastolic Heart Failure 01/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 08/2002
2	Atherosclerosis 01/2019 - 09/2007
2	Acute Coronary Syndrome 01/2018 - 01/2017
2	Nephrolithiasis 01/2018 - 02/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2017 - 01/2017
2	Heart Diseases (Heart Disease) 07/2016 - 07/2015
2	Lung Neoplasms (Lung Cancer) 09/2015 - 02/2006

Drug/Important Bio-Agent (IBA)

56	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2002
26	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2010
20	Pharmaceutical PreparationsIBA 01/2022 - 07/2002
16	SodiumIBA 01/2020 - 12/2002
15	CreatinineIBA 01/2022 - 09/2002
13	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2013 - 10/2001
12	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2017 - 11/2002
12	adducinIBA 01/2011 - 08/2002
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2002
10	CollagenIBA 01/2022 - 01/2016
10	Peptides (Polypeptides)IBA 01/2022 - 09/2012
10	CholesterolIBA 01/2021 - 11/2002
9	DiureticsIBA 01/2020 - 07/2002
7	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 01/2020
7	ProteomeIBA 12/2020 - 09/2012
7	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2010 - 08/2002
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2010
6	Insulin (Novolin)FDA Link 03/2020 - 04/2003
6	LipidsIBA 03/2020 - 08/2003
6	SaltsIBA 01/2020 - 05/2004
6	CadmiumIBA 01/2017 - 02/2006
6	Ouabain (G Strophanthin)IBA 09/2012 - 10/2005
6	1,4-dihydropyridine (dihydropyridine)IBA 05/2005 - 10/2001
5	HDL CholesterolIBA 01/2022 - 11/2006
5	CalciumIBA 01/2018 - 09/2007
5	Indapamide FDA LinkGeneric 04/2017 - 12/2006
5	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2004 - 08/2002
4	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2020
4	Matrix Gla ProteinIBA 01/2018 - 02/2015
4	Hormones (Hormone)IBA 01/2016 - 09/2007
4	Angiotensin Receptor AntagonistsIBA 11/2013 - 04/2010
4	PotassiumIBA 04/2013 - 10/2005
4	Perindopril FDA LinkGeneric 04/2011 - 01/2003
3	Biological ProductsIBA 01/2022 - 11/2010
3	Collagen Type I (Type I Collagen)IBA 01/2022 - 01/2021
3	Natriuretic PeptidesIBA 11/2021 - 03/2009
3	rostafuroxinIBA 01/2021 - 11/2010
3	Uric Acid (Urate)IBA 01/2017 - 09/2002
3	Mitochondrial DNA (mtDNA)IBA 01/2017 - 01/2016
3	ReninIBA 01/2017 - 12/2002
3	AldosteroneIBA 09/2012 - 12/2002
3	Enalapril FDA LinkGeneric 04/2010 - 10/2001
3	NitrendipineIBA 04/2010 - 10/2001
3	Angiotensin IIIBA 12/2004 - 11/2002
2	ChemokinesIBA 01/2022 - 01/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 08/2003
2	Procollagen Type IIBA 01/2022 - 01/2022
2	HDL LipoproteinsIBA 09/2021 - 07/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 08/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2020
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
2	Dietary SodiumIBA 01/2020 - 12/2016
2	Amino Acids FDA Link 01/2019 - 12/2002
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018 - 01/2012
2	Vitamin K FDA Link 01/2018 - 07/2015
2	AlbuminsIBA 09/2017 - 02/2014
2	Retinaldehyde (Retinal)IBA 12/2016 - 01/2016
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 11/2002

Therapy/Procedure

24	Therapeutics 01/2022 - 10/2001
18	Denervation 01/2019 - 01/2012
6	Sympathectomy (Sympathectomies) 01/2016 - 05/2014
5	Secondary Prevention 03/2018 - 11/2003
3	Catheters 12/2017 - 09/2013